Market Cap

Endonovo Therapeutics, Inc. Market Capitalization:

$2.7 Million

USD as of Jan. 1, 2024

Endonovo Therapeutics, Inc. Company Profile

Endonovo Therapeutics, Inc. Main Stock Listing

OTC: ENDV

Market Capitalization History of Endonovo Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$461.52 B
Vertex Pharmaceuticals Incorporated	$107.23 B
Regeneron Pharmaceuticals, Inc.	$100.01 B
CSL Limited	$94.74 B
Marinomed Biotech AG	$73.23 B

Sector: Healthcare

Company	Market Cap (USD)
Lilly	$586.39 B
UnitedHealth Group	$504.47 B
Novo Nordisk	$461.52 B
Johnson & Johnson	$387.50 B
Merck	$296.51 B

Yearly evolution of Endonovo Therapeutics, Inc. market cap

Date	Market Cap	YoY Change
Jan. 1, 2024	$2.7 M	-26.62%
Jan. 1, 2023	$3.7 M	-5.00%
Jan. 1, 2022	$3.9 M	-58.33%
Jan. 1, 2021	$9.3 M	-98.29%
Jan. 1, 2020	$544.1 M	-89.78%
Jan. 1, 2019	$5.32 B	-45.20%
Jan. 1, 2018	$9.72 B	47.93%
Jan. 1, 2017	$6.57 B	-92.40%
Jan. 1, 2016	$86.48 B	-64.40%
Jan. 1, 2015	$242.91 B	-85.96%
Jan. 1, 2014	$1.730 T	-40.67%
Jan. 1, 2013	$2.915 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Endonovo Therapeutics, Inc. Categories

United States Healthcare Biotechnology

United States Healthcare

United States Biotechnology

Stocks & Indices

Endonovo Therapeutics, Inc. has the following listings and related stock indices.

Stock: OTC: ENDV

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.